UPADACITINIB WAS NOT ASSOCIATED WITH ANAEMIA IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE U-ACHIEVE STUDY

被引：0
|
作者：
D'Haens, Geert R.
Hebuterne, Xavier
Higgins, Peter D.
Loftus, Edward V.
Zhou, Wen
Lacerda, Ana P.
Xie, Wangang
Liu, Jianzhong
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1889
引用
收藏
页码：S1205 / S1206
页数：2
相关论文
共 50 条
  • [31] The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indications
    Colombel, J. F.
    Panaccione, R.
    Nakase, H.
    Burmester, G.
    Cohen, S. B.
    Mease, P.
    Guttman-Yassky, E.
    Liu, J.
    Zhou, W.
    Ilo, D.
    Higgins, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I514
  • [32] The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indications
    Colombel, J. F.
    Panaccione, R.
    Nakase, H.
    Burmester, G.
    Cohen, S. B.
    Mease, P.
    Guttman-Yassky, E.
    Liu, J.
    Zhou, W.
    Ilo, D.
    Higgins, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I514
  • [33] Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE
    Verstockt, B.
    Polakow, S. Blink
    Mahi, N.
    Lee, J.
    Wang, J.
    Guay, H.
    Salas, A.
    Panes, J.
    Ungaro, R. C.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I033 - I034
  • [34] THE SAFETY PROFILE OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS IN THE PHASE 3 U-ACHIEVE STUDY IS CONSISTENT WITH THAT IN APPROVED INDICATIONS
    Colombel, Jean Frederic
    Panaccione, Remo
    Nakase, Hiroshi
    Burmester, Gerd R.
    Cohen, Stanley B.
    Mease, Philip
    Guttman-Yassky, Emma
    Liu, Jianzhong
    Zhou, Wen
    Ilo, Dapo
    Higgins, Peter D.
    GASTROENTEROLOGY, 2022, 162 (07) : S967 - S967
  • [35] Rapidity of Symptom Control with Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two Randomized Phase 3 Studies
    Loftus, Edward V.
    Takeuchi, Ken
    Gao, Xiang
    Panaccione, Remo
    Danese, Silvio
    Ilo, Dapo
    Finney-Hayward, Tricia
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S359 - S359
  • [36] THE EFFECT OF OZANIMOD ON CIRCULATING NEUTROPHILS: RESULTS FROM THE TRUE NORTH STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Harris, Sarah
    Wu, Chun
    Li, Yicong
    Maddux, Rachel
    Hu, Sarah
    Petersen, AnnKatrin
    GASTROENTEROLOGY, 2022, 162 (07) : S973 - S973
  • [37] CORTICOSTEROID-FREE REMISSION THROUGH 2 YEARS OF UPADACITINIB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Dubinsky, Marla C.
    Atreya, Raja
    Abreu, Maria T.
    Nakase, Hiroshi
    Danese, Silvio
    Kujawski, Michelle
    Garrison, Andrew
    Eccleston, Jason
    Panaccione, Remo
    GASTROENTEROLOGY, 2024, 166 (05) : S812 - S813
  • [38] Corticosteroid-free remission through 2 years of upadacitinib therapy in patients with moderately to severely active ulcerative colitis
    Dubinsky, Marla
    Atreya, Raja
    Abreu, Maria
    Nakase, Hiroshi
    Danese, Silvio
    Kujawski, Michelle R.
    Garrison, Andrew
    Eccleston, Jason
    Smith, Rebecca
    Panaccione, Remo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 164 - 164
  • [39] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
    Panes, Julian
    Loftus, Edward, V
    Higgins, Peter D. R.
    Lindsay, James O.
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Phillips, Charles
    Tran, Jacinda
    Sanchez Gonzalez, Yuri
    Vermeire, Severine
    INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
  • [40] Pharmacokinetics of Adalimumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
    Awni, Walid M.
    Eckert, Doerthe
    Sharma, Shringi
    Mostafa, Nael M.
    Noertersheuser, Peter A.
    Pradhan, Rajendra S.
    Robinson, Anne
    Sandborn, William
    Hanauer, Stephen B.
    Colombel, Jean-Frederic
    Thakkar, Roopal
    GASTROENTEROLOGY, 2013, 144 (05) : S229 - S229
12345